Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Current Deferred Revenue: 2009-2012

Historic Current Deferred Revenue for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $421,000.

  • Lexicon Pharmaceuticals' Current Deferred Revenue rose 156.71% to $421,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $421,000, marking a year-over-year increase of 156.71%. This contributed to the annual value of $119,000 for FY2011, which is 44.39% down from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Current Deferred Revenue of $421,000 as of Q3 2012, which was down 0.00% from $421,000 recorded in Q2 2012.
  • Lexicon Pharmaceuticals' 5-year Current Deferred Revenue high stood at $3.1 million for Q1 2009, and its period low was $119,000 during Q4 2011.
  • For the 3-year period, Lexicon Pharmaceuticals' Current Deferred Revenue averaged around $365,455, with its median value being $421,000 (2012).
  • Per our database at Business Quant, Lexicon Pharmaceuticals' Current Deferred Revenue slumped by 81.47% in 2010 and then spiked by 205.07% in 2012.
  • Lexicon Pharmaceuticals' Current Deferred Revenue (Quarterly) stood at $942,000 in 2009, then tumbled by 77.28% to $214,000 in 2010, then tumbled by 44.39% to $119,000 in 2011, then surged by 156.71% to $421,000 in 2012.
  • Its Current Deferred Revenue was $421,000 in Q3 2012, compared to $421,000 in Q2 2012 and $421,000 in Q1 2012.